155 related articles for article (PubMed ID: 24756926)
1. Gender-related differences in pathological and clinical tumor response based on immunohistochemical proteins expression in rectal cancer patients treated with short course of preoperative radiotherapy.
Gasinska A; Adamczyk A; Niemiec J; Biesaga B; Darasz Z; Skolyszewski J
J Gastrointest Surg; 2014 Jul; 18(7):1306-18. PubMed ID: 24756926
[TBL] [Abstract][Full Text] [Related]
2. Gender-related prognostic significance of clinical and biological tumor features in rectal cancer patients receiving short-course preoperative radiotherapy.
Gasinska A; Darasz Z; Adamczyk A; Biesaga B; Niemiec J; Reinfuss M
Rep Pract Oncol Radiother; 2017; 22(5):368-377. PubMed ID: 28794690
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
4. Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients.
Gasinska A; Richter P; Darasz Z; Niemiec J; Bucki K; Malecki K; Sokolowski A
J Gastrointest Surg; 2011 Sep; 15(9):1568-76. PubMed ID: 21706276
[TBL] [Abstract][Full Text] [Related]
5. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
6. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
7. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
[TBL] [Abstract][Full Text] [Related]
10. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.
Pach R; Kulig J; Richter P; Gach T; Szura M; Kowalska T
Langenbecks Arch Surg; 2012 Jun; 397(5):801-7. PubMed ID: 22170083
[TBL] [Abstract][Full Text] [Related]
12. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
13. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer.
Adell G; Zhang H; Jansson A; Sun XF; Stål O; Nordenskjöld B
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):659-63. PubMed ID: 11395233
[TBL] [Abstract][Full Text] [Related]
14. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
17. Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer.
Arezzo A; Arolfo S; Allaix ME; Munoz F; Cassoni P; Monagheddu C; Ricardi U; Ciccone G; Morino M
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):299-306. PubMed ID: 25772184
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
20. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.
Berger C; de Muret A; Garaud P; Chapet S; Bourlier P; Reynaud-Bougnoux A; Dorval E; de Calan L; Huten N; le Folch O; Calais G
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):619-27. PubMed ID: 9112461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
